Comprehensive overview of detecting and treating pancreatic cancer
Detecting pancreatic cancer effectively relies on several critical diagnostic tools. Key among them is the pancreatic biopsy, a definitive test for identifying cancerous cells. Imaging ... Read More
Understanding Pancreatic Cancer: Incidence, Symptoms, and Prevention
Pancreatic cancer, medically termed "Pancreatic Carcinoma," is a serious condition originating in the pancreas, an essential organ located behind the stomach. The pancreas plays a ... Read More
Exploring Marine Cytotoxic Compounds in Cancer Treatment
Marine organisms offer a vast reservoir of cytotoxic compounds with potential therapeutic applications in treating various cancers. These biomedicines, known as marine drugs, are derived ... Read More
Health Hazards of Smoking and Nicotine Addiction
Nicotine, a potent chemical found in tobacco leaves, is the primary reason people become addicted to smoking cigarettes and cigars. This substance stimulates the nervous ... Read More
Study links high doses of Vitamin B supplements to increased lung cancer risk in men
A study has highlighted a significant health concern for men who consume high doses of vitamin B supplements, particularly vitamins B6 and B12. According to ... Read More
Zydus introduces cancer treatment IBYRA in India, making advanced therapy accessible
In a groundbreaking development for cancer treatment in India, Zydus Lifesciences has launched Olaparib under the brand name IBYRA, a pioneering PARP inhibitor designed to ... Read More
Kinnate Biopharma agrees to merger with XOMA, boosting shareholder value and advancing cancer research
Kinnate Biopharma Inc. (Nasdaq: KNTE), a leading clinical-stage precision oncology company, has announced a definitive merger agreement with XOMA Corporation, setting the stage for a ... Read More
Buckingham Palace confirms King Charles’s cancer diagnosis and treatment plan
In a sobering announcement from Buckingham Palace on Monday, it was revealed that King Charles III has been diagnosed with an unspecified type of cancer, ... Read More
Gilead Sciences invests $320m in Arcus Biosciences to accelerate cancer treatment innovations
Gilead Sciences, Inc. (Nasdaq: GILD) and Arcus Biosciences, Inc. (NYSE: RCUS) have announced a significant amendment to their collaboration agreement, accompanied by a substantial $320 ... Read More
Bristol Myers Squibb’s subcutaneous nivolumab shows promise in Phase 3 RCC trial
Bristol Myers Squibb (NYSE: BMY) has announced results from its Phase 3 CheckMate -67T trial, which could revolutionize treatment for patients with advanced or metastatic ... Read More